https://myphora.org/ishlt-derivation-of-a-bayesian-network-model-from-an-existing-risk-score-calculator-for-pulmonary-arterial-hypertension/2020-07-23T15:44:00+00:00https://myphora.org/new-publication-the-use-of-risk-assessment-tools-and-prognostic-scores-in-managing-patients-with-pulmonary-arterial-hypertension/2020-07-23T15:43:46+00:00https://myphora.org/new-publication-bayesian-network-vs-coxs-proportional-hazard-model-of-pah-risk-a-comparison/2020-07-23T15:43:31+00:00https://myphora.org/risk-stratification-in-pulmonary-arterial-hypertension-using-bayesian-analysis/2022-07-18T16:13:02+00:00https://myphora.org/a-bayesian-network-interpretation-of-the-coxs-proportional-hazard-model/2020-07-23T15:44:10+00:00https://myphora.org/ats-bayesian-network-modeling-the-future-of-pulmonary-arterial-hypertension-risk-stratification-through-the-phora-initiative/2022-07-18T16:07:15+00:00https://myphora.org/ats-pulmonary-arterial-registry-risk-algorithms-improve-upon-clinical-trial-enrichment-methodology/2020-07-23T15:42:36+00:00https://myphora.org/ats-upfront-combination-versus-monotherapy-in-pulmonary-arterial-hypertension-pah-can-advanced-risk-stratification-tell-us-the-real-benefit/2020-07-23T18:57:38+00:00https://myphora.org/chest-hemodynamic-parameters-in-predicting-survival-in-pulmonary-arterial-hypertension/2020-07-23T19:20:07+00:00https://myphora.org/ats-application-of-machine-learning-in-pulmonary-arterial-hypertension-risk-stratification/2020-07-23T19:40:43+00:00https://myphora.org/enrichment-benefits-of-risk-algorithms-for-pulmonary-arterial-hypertension-clinical-trials/2020-09-24T17:26:53+00:00https://myphora.org/ishlt-2021-hemodynamic-parameters-in-predicting-survival-in-pulmonary-arterial-hypertension/2022-03-28T16:23:35+00:00https://myphora.org/hemodynamic-parameters-in-predicting-time-to-clinical-worsening-in-pulmonary-arterial-hypertension/2022-03-28T16:58:39+00:00https://myphora.org/chest-2021-effective-communication-of-machine-learning-models-in-clinical-decision-support-tools-for-pah-risk-prediction/2022-05-18T16:13:21+00:00https://myphora.org/chest-2021-ekg-parameters-in-predicting-survivals-in-pulmonary-arterial-hypertension%ef%bf%bc/2022-05-18T16:12:44+00:00https://myphora.org/chest-2021-lab-parameters-in-predicting-survival-in-pulmonary-arterial-hypertension/2022-03-29T13:38:19+00:00https://myphora.org/aha-association-of-canonical-pathways-with-length-of-survival-in-pulmonary-arterial-hypertension/2022-05-18T16:13:55+00:00https://myphora.org/ishlt-2022-clinical-variables-in-predicting-survival-and-hospitalization-for-pulmonary-arterial-hypertension-using-harmonized-data/2022-05-18T16:26:19+00:00https://myphora.org/poster-at-pha-2022-conference-pulmonary-arterial-hypertension-risk-assessment-genomic-model-using-bayesian-network/2022-07-07T15:05:36+00:00https://myphora.org/poster-at-pha-2022-conference-pulmonary-arterial-hypertension-risk-assessment-model-using-random-forrest-and-bayesian-network/2022-07-07T21:19:00+00:00https://myphora.org/poster-at-pvri-congress-2022-comparison-between-pah-risk-assessment-methods-including-phora/2022-07-07T19:36:34+00:00https://myphora.org/poster-at-ers-international-congress-2022-pulmonary-arterial-hypertension-risk-assessment-model-using-bayesian-network-analysis/2023-11-15T18:40:39+00:00https://myphora.org/presentation-at-chest-annual-meeting-2022-comparison-between-pulmonary-arterial-hypertension-pah-risk-assessment-methods-including-pulmonary-hypertension-outcome-risks-assessment-phora/2023-11-15T19:10:54+00:00https://myphora.org/aha-2022-identification-of-novel-right-ventricular-function-phenotypes-in-pulmonary-arterial-hypertension-using-unbiased-k-means-clustering/2023-11-15T19:22:31+00:00https://myphora.org/article-in-chest-do-patients-with-low-risk-pulmonary-arterial-hypertension-really-benefit-from-upfront-combination-therapy-insight-from-the-ambition-trial/2023-11-15T20:21:44+00:00https://myphora.org/improvement-of-pulmonary-arterial-hypertension-risk-assessment-model-using-cardiac-magnetic-resonance-imaging-variables/2023-12-21T16:30:03+00:00https://myphora.org/aha-2023-comparison-of-pulmonary-arterial-risk-assessment-tools-using-a-harmonized-fda-dataset/2023-12-21T16:24:11+00:00https://myphora.org/aha-2023-novel-imaging-hemodynamic-based-right-ventricular-phenotypes-in-patients-with-pulmonary-hypertension/2023-12-21T16:29:03+00:00